EYEN: Eyenovia, Inc. Common Stock Company Profile & Statistics

About

Eyenovia, Inc. is a clinical stage biopharmaceutical company which engages in developing therapeutics for the treatment of prominent eye diseases primarily in the United States. Its product portfolio includes MicroProst, MicroStat, MicroTears and MicroPine which are in clinical stage. Eyenovia, Inc. is based in New York.

Info & Links

CEO

Michael Rowe

Headquarters

295 MADISON AVENUE, SUITE 2400
NEW YORK, NY 10017, UNITED STATES

Auditor

Marcum LLP

Share holders

Employees

Eyenovia, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.84M

Enterprise Value

6.22M

Enterprise Value/EBITDA(ttm)

-0.18

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

73.02

Price to Book(mrq)

0.50

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-516.84%

Operating Margin(ttm)

-102142.42%

Profit Margin(ttm)

-143833.66%

Return on Equity(ttm)

-1108.24%

Return on Invested Capital(ttm)

-817.46%

Return on Assets(ttm)

-139.36%

Income Statement

Revenue(ttm)

31.80K

Revenue Per Share(ttm)

0.03

Gross Profit(ttm)

-598.60K

EBITDA(ttm)³

-34.91M

Net Income Available to Common(ttm)

-37.83M

Diluted EPS(ttm)

-58.40

Share Statistics

Beta (5Y Monthly)

1.24

52-Week Change

-98.64%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

1.08M

Dividend Yield

0.00%

Float⁴

1.29M

% Held by Insiders

7.10%

% Held by Institutions

25.84%

Balance Sheet

Total Cash(mrq)

7.19M

Total Cash Per Share(mrq)

6.65

Total Debt(mrq)

11.57M

Total Debt/Equity(mrq)

311.10%

Current Ratio(mrq)

0.74%

Quick Ratio(mrq)

0.55%

Book Value Per Share(mrq)

3.44

Cash Flow

Operating Cash Flow Per Share(ytd)

-27.61

Free Cash Flow(ytd)

-24.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

EYEN

Eyenovia, Inc. Common Stock

Eyenovia, Inc. Common Stock Profile